Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BNA
|
|||
| Former ID |
DIB013681
|
|||
| Drug Name |
RF1V
|
|||
| Indication | Parasitic infection [ICD-11: 1D0Y-1G2Z; ICD-10: B85-B89] | Phase 2 | [1] | |
| Company |
DynPort Vaccine Company
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CSC's dynport vaccine company initiates phase 2b clinical trial of plague vaccine for u.s. department of defense. CSC. October 06, 2010. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.